InMed Pharmaceuticals (INM) Research & Development: 2021-2025
Historic Research & Development for InMed Pharmaceuticals (INM) over the last 4 years, with Sep 2025 value amounting to $581,612.
- InMed Pharmaceuticals' Research & Development fell 16.93% to $581,612 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 1.48%. This contributed to the annual value of $2.9 million for FY2025, which is 11.30% down from last year.
- Per InMed Pharmaceuticals' latest filing, its Research & Development stood at $581,612 for Q3 2025, which was up 415.98% from $112,720 recorded in Q2 2025.
- InMed Pharmaceuticals' Research & Development's 5-year high stood at $2.5 million during Q4 2021, with a 5-year trough of $112,720 in Q2 2025.
- For the 3-year period, InMed Pharmaceuticals' Research & Development averaged around $734,915, with its median value being $658,869 (2024).
- As far as peak fluctuations go, InMed Pharmaceuticals' Research & Development surged by 73.89% in 2024, and later tumbled by 82.89% in 2025.
- Quarterly analysis of 5 years shows InMed Pharmaceuticals' Research & Development stood at $2.5 million in 2021, then tumbled by 66.44% to $851,356 in 2022, then fell by 28.37% to $609,791 in 2023, then soared by 73.89% to $1.1 million in 2024, then declined by 16.93% to $581,612 in 2025.
- Its Research & Development stands at $581,612 for Q3 2025, versus $112,720 for Q2 2025 and $909,653 for Q1 2025.